Typhoid IgG/IgM Rapid Test Device

The Typhoid IgG/IgM Rapid Test Device is an antibody-based rapid diagnostic test used to detect and differentiate IgG and IgM antibodies against Salmonella Typhi or Paratyphi. IgM antibodies may suggest recent or active infection, while IgG antibodies may suggest past exposure, later-stage infection, or immune response.

• The Typhoid IgG/IgM Rapid Test Device helps support faster screening when typhoid fever is suspected.
• Symptoms of typhoid may overlap with viral fever, malaria, dengue, gastroenteritis, and other infectious diseases.
• Because of this overlap, rapid screening can help healthcare professionals decide the next diagnostic step.
• Typhoid fever commonly spreads through contaminated food or water and remains a concern in regions with unsafe sanitation, poor hygiene, and limited access to clean drinking water.

The Typhoid IgG/IgM Rapid Test Device by LARKSOIS Pharma may be used in professional infectious disease and fever screening environments.

Applications

• Suspected typhoid fever screening
• Fever investigation in endemic regions
• Differentiation of IgG and IgM immune response
• Clinical decision support
• Hospital and laboratory workflows
• Public health screening programs
• Travel-related fever evaluation
• Point-of-care infectious disease testing
• Diagnostic centers

• The Typhoid IgG/IgM Rapid Test Device generally works on a lateral flow immunochromatographic assay principle.
• A whole blood, serum, or plasma sample is added to the sample well, followed by buffer if required.
• The sample migrates across the membrane by capillary action.
• If anti-Salmonella Typhi IgG or IgM antibodies are present, they bind to test reagents and produce visible colored lines in the IgG and/or IgM regions.
• A control line confirms that the test has run properly.

The Typhoid IgG/IgM Rapid Test Device uses rapid lateral flow immunochromatographic technology for qualitative detection and differentiation of IgG and IgM antibodies against Salmonella Typhi and Paratyphi in whole blood, serum, or plasma specimens.

Benefits

• Rapid antibody-based typhoid screening
• Detects both IgG and IgM antibodies
• Helps differentiate recent and past immune response
• Suitable for whole blood, serum, or plasma
• Simple lateral flow format
• No complex equipment required
• Professional diagnostic application
• Useful for hospitals, clinics, and laboratories

The Typhoid IgG/IgM Rapid Test Device is designed for human whole blood, serum, or plasma specimens. Correct specimen collection and handling are important for reliable rapid test performance.

Guidance

• Use approved whole blood, serum, or plasma specimens only
• Collect specimens according to the product insert
• Use clean and suitable sample collection materials
• Avoid contaminated or improperly stored samples
• Apply the specimen correctly to the sample well
• Add buffer if required according to instructions
• Read results only within the recommended time window
• Handle all blood specimens as potentially infectious material

Note

Specimen collection, testing, timing, and storage should always follow the official LARKSOIS Pharma kit insert.

The Typhoid IgG/IgM Rapid Test Device by LARKSOIS Pharma is designed for qualitative detection and differentiation of IgG and IgM antibodies against Salmonella Typhi and Paratyphi in whole blood, serum, or plasma specimens.

• The Typhoid IgG/IgM Rapid Test helps support screening in patients with prolonged fever and suspected enteric fever.
• The test is suitable for hospitals, diagnostic laboratories, clinics, and public health screening settings.
• In regions where typhoid is common, rapid IgG/IgM testing can support faster preliminary assessment.
• The test may support evaluation of patients returning from areas with typhoid transmission risk.
• The rapid cassette format supports near-patient testing where quick screening is needed.

The Typhoid IgG/IgM Rapid Test Device is a screening aid, not a standalone final diagnosis. Results should be interpreted with symptoms, fever duration, clinical history, exposure risk, and confirmatory testing when required.

Instructions

• For professional in-vitro diagnostic use only
• Use approved whole blood, serum, or plasma specimens only
• Improper specimen collection may affect results
• False positive or false negative results may occur
• Early infection may require repeat or confirmatory testing
• Clinical evaluation should guide final diagnosis and patient management
• Read results only within the recommended time
• Follow the official product insert carefully

Instructions

• Rapid antibody-based typhoid screening
• Detects both IgG and IgM antibodies
• Helps differentiate recent and past immune response
• Suitable for whole blood, serum, or plasma
• Simple lateral flow format
• No complex equipment required
• Professional diagnostic application
• Designed for international healthcare markets

Note

The Typhoid IgG/IgM Rapid Test Device by LARKSOIS Pharma is a reliable infectious disease rapid test developed for professional healthcare use.

Steps

• Bring the test device, specimen, and buffer to room temperature
• Open the sealed pouch only when ready to test
• Place the test device on a clean and flat surface
• Add whole blood, serum, or plasma to the sample well
• Add buffer if required according to the product insert
• Wait for the recommended reaction time
• Read the IgG, IgM, and control lines within the valid time window
• Do not interpret results after the recommended reading time
• Dispose of used materials according to laboratory safety procedures

Note

Testing should be performed by trained healthcare professionals according to the official LARKSOIS Pharma product insert.

Positive

IgM positive may suggest recent or active typhoid/paratyphoid infection. IgG positive may suggest past exposure, later-stage infection, or immune response. IgG and IgM positive may suggest ongoing infection, recent exposure, or transition stage of immune response.

Negative

No detectable IgG/IgM antibodies were found at the test detection limit. Early infection may still require repeat or confirmatory testing.

Invalid

Control line does not appear; repeat testing is required using a new device.

Instructions

• Store as per product label instructions
• Keep sealed until use
• Protect from heat, sunlight, and moisture
• Do not freeze unless specified
• Use before expiry date
• Use proper sample handling precautions
• Follow the instructions for use carefully
• Use immediately after opening the pouch

Instructions

• For professional in-vitro diagnostic use only
• Handle all blood specimens carefully
• Wear gloves and protective equipment during testing
• Do not reuse the test device
• Avoid specimen contamination
• Do not use damaged or expired kits
• Read results only within the recommended time
• Interpret results with clinical findings and patient history

LARKSOIS Pharma provides rapid diagnostic products designed for global healthcare markets. The Typhoid IgG/IgM Rapid Test Device supports professional infectious disease screening with simple handling, rapid results, and practical diagnostic workflow.

Advantages

• International infectious disease rapid test portfolio
• Export-ready diagnostic product range
• Suitable for hospitals, clinics, and laboratories
• Professional healthcare quality focus
• Practical point-of-care testing format
• Reliable supply support for distributors
• Designed for global diagnostic requirements